chrisvoncsefalvay/vaers-outcomes huggingface dataset:
immediately following injection within 1-2 minutes, she developed severe facial flushing followed by flushing and redness of the bilateral forearms and hands. She received 25mg of Benadryl and was observed for 1 hour. Symptoms resolved within the next hour or so. S
Injection site was red, very painful, and swollen.  About 30 hrs after injection I experienced joint pain, overall not feeling well, and chest tightness (different than my last anxiety attack).  12 hours later those symptoms were gone but then I had a headache and nausea that resolved shortly after.
Lightheadedness, "brain fog", large drop in bp down to 94/58, heart rate dropped from 82 to 62, difficulty focusing eyes, nystagmus in left eye, unsteady balance.  Events were present for over 3 weeks before beginning to fade.
macular papular rash on trunk,chest,arms & face w/swelling of face & periorbital edema;no resp sx;no local rxn;treated w/DPH & steroids
Fever of 100+ degrees for 12 consecutive hours. During which fever reached 101.7 for several of those hours.
SORE ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sore arm. This report was non-serious.
Severe hives on face, back, and arms. Shortness of breath started at 10 pm, 6 hours after the dose.  Hives lasted 2 days, shortness of breath is now a chronic problem when exertion occurs.
PATIENT DEVELOPED RED WELT AT INJECTION SITE.  DAYS LATER WAS LATER DIAGNOSED AT URGENT CARE FACILITY WITH CELLULITIS AND GIVEN ANTIBIOTIC KEFLEX ORALLY
experienced fast heart beat; little lightheadedness; This is a spontaneous report from a contactable consumer (patient) reported for herself. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Batch/Lot number was not reported) via an unspecified route of administration on 17Mar2021 11:30 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 17Mar2021, the patient experienced fast heartbeat started around 12:50 after the vaccine and stated that she is feeling better now just a little lightheadedness on unspecified date in Mar2021 but other than that she is good and wanted to know what she should do. The patient underwent lab tests and procedures which included heartbeat resulted as experienced fast on 17Mar2021. The clinical outcome of the events was resolving.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
pt received 1st dose of Moderna bivalent 6mo-5yrs formulation (10mcg/0.2mL) and should have received Moderna Bivalent formulation 25mcg/0.25mL
GOT COVID (3.5 WEEKS) AFTER VACCINATION; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced got covid (3.5 weeks) after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got covid (3.5 weeks) after vaccination was not reported. This report was non-serious. This case, from the same reporter is linked to 20211212581.
manufacuer: seqirus hd for 65 yoa Swelling,  2r: 1 inch,  right a way as the needle out. After  around 10 minutes,  don't fell well- palpitation, cold and hurt around the neck.  Pharmacist give 2 tablets 25 mg ( 50 mg ) diphenhydramine by mouth.  Monitor blood pressure: 219/173 - 70 and 5 minutes after 186/97 - 70 . Patient ask to all 911
VACCINE ADMINISTERED  AT 11:40AM, PT HAD PASSED OUT AFTER 2ND DOSE, SO SHE REMAINED SEATED AFTER VACCINE. AT APPROX 11:43AM, PATIENT BECAME LIMP--HEAD DROPPED, AND WAS VERY PALE BUT RESPONSIVE.  EYES WERE FLUTTERY. AT 11:48AM HER FATHER LIFTED HER ONTO THE FLOOR AND COLOR STARTED RETURNING AND SHE WAS FULLY AWARE AT THAT POINT.  REMAINED LYING DOWN FOR 10 MORE MINUTES THEN SLOWLY GOT UP AND LEFT WITH PARENTS AT 12:10, UPRIGHT AND LOOKING FINE
Left axilla- Swollen painful lymph nodes  x5 days, started 6 days after vaccine administration Left arm around injection site- Red circle 3 inch diameter, itching, sensitive to touch, palpable 2cm bump at injection site x5 days, started 6 days after vaccine administration
I got the vaccine on Friday 10/22. On Monday 10/25 my feet and legs (primarily calves and just above my knees) were both very swollen. I read that swollen legs could be a severe reaction so I went to urgent care and they sent me to the ER. The ER was overcrowded so they did some bloodwork to check my kidneys I think and said to follow up with my primary care doctor. The next day, Tuesday 10/26, I started feeling "pins and needles" in my hands, feet, and face. The swelling went away after about five days. The nerve pain has not gone away although it has gotten slightly lesser in intensity.
I woke up at 1 am to go to bathroom , I fainted in hallway , waking up husband. I then came to , didn?t feel good and vomited 4 times with no energy. The following day facial swelling at 1 am . Could be from fall . Very bad migraine until Saturday afternoon.
Information has been received from a female consumer who was vaccinated with rubella virus vaccine live (manufacturer unknown) when she was a small child. When the patient became pregnant, she was checked for antibodies. Laboratory evaluations revealed there were no antibodies. The patient had to get re-vaccinated. The patient sought unspecified medical attention. Additional information has been requested.
12:38PM PT C/O 'THROAT FEELS TIGHT-DENIES SOB OR DYSPNEA'. A/O, PINK, W/D, RESP WITHOUT DISTRESS. BENADRYL 50MG PO (1 CHEWED/1 SWALLOWED). 12:52PM 'FEELS A LITTLE BETTER'.RESP REG WITH EASE. 1:35PM  STATES 'IMPROVED'. A/O, PINK, PINK, W/D, NO RESP DISTRESS. SUGGESTED TO TAKE BENADRYL 25-50MG  AT 4PM AND 8PM THEN A CLARITIN AT BEDTIME. ALSO CHECK WITH PCP R/T DOSE #2.  2-25-21 10AM TC-PT STATES SHE 'FEELS BETTER, BUT THROAT IS NOW DRY FROM CLARITIN'.  STATES SHE SAW HER PCP THIS AM AND WAS ADVISED NOT TO TAKE DOSE #2.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On an unknown date the patient was vaccinated with an unidentified "rubella vaccine" (manufacturer unknown) (name, lot #, dose and route were unspecified). On an unknown date the patient had an unspecified allergic reaction to the "rubella vaccine". The outcome of the event was not provided. The reporter considered the event to be related to the unidentified "rubella vaccine" (manufacturer unknown). Additional information has been requested.
From initial information received on October 15,2003 from the patient regarding an adverse event occurring in the USA, it was reported that a female patient (age and birth not reported) received Fluzone SV '2003-2004' UPS, lot number U1097AA, administered intra-muscularly in the left deltoid on October 09,2003.  One day later, the patient developed a fever, chills, general malaise, and "flu-like symptoms".  The patient was prescribed Tylenol and advised to force fluids.  The patient's medical conditions include immunosuppression and at the time of vaccination the patient had a compromised immune system.  Reportedly, the patient recovered from this event. From additional information received on 01/14/2004 from the responsible physician, it was reported that the patient received the Fluzone SV '2003-2004' vaccination on October 02,2003, not October 09,2003 as previously reported.  Additionally, the adverse event onset date was updated to October 03,2003, not October 10,2003 as previously reported.  The patient's date of birth and contact information were also provided.
Severe fatigue, body aches, chills, fever and cold sweats. Lasted approx 12 hours and then subsided.
New patient to me but established with other Dr. Here with Mom and Dad. Rash first noted this morning. Dad shows me cell phone pics from earlier as rash has faded now- Fever started yesterday; got two doses of acetaminophen-none since 6:30p. Nursing well; acting OK overnight but felt warm and went back to sleep after nursing OK. Not itchy, not rubbing, not fussy, feeding fine no runny nose; no change in dry/play cough no V/D. AQUAPHOR but nothing new-last around 7 or 8pm Baths: J and J Lavendar and BABY MAGIC-had bath last night. Let him try a little pear at 6pm last night - no issues. No prior issues with vaccines. Yesterday's WCC reviewed- no issues -  received PEDIARIX, HIB, PREVNAR and ROTARIX vaccines (set #2).
On 12/6/06, Employee reported that approximately 2 hours post vaccination, developed cold-like symptoms to include coughing, scratchy throat, sinus headaches.  Denied fever or chills.  Symptoms worsened since initial report on 12/06/06. Referred for further follow-up.
only 1st dose administrated on 2020.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix on 20th September 2020 from batch number h552g with expiry date 20th September 2022).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 01-Apr-2022 Reporter's comment: The patient was late for the second dose of Shingrix. No adverse event was reported. The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose, which led to incomplete course of vaccination.
Patient received 1ml dose of influenza vaccine instead of correct 0.5ml dose. Patient reported nothing expect slight soreness at site of injection.
No adverse effects reported; Received an improperly stored dose; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and historical drugs, drug reactions and allergies was not provided. The patient's concomitant therapies included sterile diluent.   On 09-MAY-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # N034551, expiration date 05-DEC-2019 (strength, dose, route and anatomical location were not provided) for prophylaxis. The vaccine was exposed to a temperature range of -14°C to -10°C (-14.3°C) during 2 hours and 7 minutes. There was previous temperature from -14°C to -10°C (-12.8°C) for 51 minutes and from -9°C to 8°C (-8.2°C) for 37 minutes. It was reported that digital data logger was involved. No adverse effects were reported.  This is one of 4 reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA012683: US-009507513-1905USA012682: US-009507513-1905USA012684:
Tested positive for Covid 19 on September 17, 2021 - asymptomatic
I received my vaccine on 2/10/21. I had expected side effects of fevers, chills, body aches, headache on 2/11 - 2/13. I continued with a persistent headache throughout the week. A presure in my head, worse with standing up, and it made me dizzy when I stood up. On the night of 2/18/21 I developed left sided ear pain. On 2/19/21 I developed a left sided otitis media. On 2/21/21 I developed sudden onset left sided facial droop. I had a negative head CT, and was diagnosed with bells palsy related to the swelling in my ear from the otitis media.   I continue to have significant ear pain, and left sided facial paralysis today.
Fevers 100-102.3 x 4 days. Motrin administered every 6 hours.
Erythematous papular rash - some with central blanching, some hive-like scattered diffusely. Appeared gradually the day after IPV. No Rx.
Entire body covered in hives/Diagnosed with chronic idiopathic hives; Angioedema; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Aug2021 as dose 2, single (Batch/Lot number: unknown) at the age of 34 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa meds" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: 04Aug2021, when the patient was 34-year-old, for Covid-19 Immunization. The following information was reported: ANGIOEDEMA (medically significant) with onset 17Mar2023 at 12:00, outcome "not recovered"; IDIOPATHIC URTICARIA (medically significant) with onset 17Mar2023 at 12:00, outcome "not recovered", described as "Entire body covered in hives/Diagnosed with chronic idiopathic hives". The events "entire body covered in hives/diagnosed with chronic idiopathic hives" and "angioedema" required physician office visit.  The adverse event detail information included entire body covered in hives; angiodema and seen rheumatoid arthritis doctor, regular doctor, and allergist, and dermatologist; Diagnosed with chronic idiopathic hives; Nothing gave relief. Therapeutic measures were taken as a result of idiopathic urticaria, angioedema included Xolair shot, zyrtec, Pepcid, atarax, Benadryl, sin.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Vomiting, fever to 103 degrees. Fever was noted (rectal) 102.7 on admit to ER, uncontrollable vomiting. Dehydration. Neuro signs intact. Received IV fluids, ZOFRAN 1 mg IVP and TYLENOL 110mg.
Severe neck and back muscle pain. Physical therapy was partially effective, but the pain continues to this date in the lower back muscles. Treatment consists of naproxen and direct application of lidocaine  cream.
(L) leg swollen, painful after flu vaccine. BENADRYL, Acetaminophen PRN.
soreness at injection site; This is a spontaneous report from two contactable consumers. An adult female patient of an unknown age received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on an unspecified date (Lot number was not reported) as single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if patient received any other vaccines within four weeks prior to the vaccination. Patient did not have COVID prior vaccination. The patient was tested for COVID post vaccination, date and results unknown. On an unspecified date patient experienced soreness at injection site. No treatment was received. Patient recovered from the event on unknown date. No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Onset of fever to 103.6F, 24 hours, post vax, with vomiting, flu-like symptoms, chest pressure, joint pains, fatigue and called PCP on Tuesday, 8/20/02. On 8/22/02, still has a temperature of 100.9F, joint pains and fatigue. Still recovering.
Discovered after vaccination was given than Mother had lied about DOB on req form when patients actual DOB was different, which makes him under 12 years old and not eligable for vaccine.
Patient reported a red, sore, 2 inch rash at the injection site. It occurred two days after injection.
Four days post-vaccination, had "jolts" to left side of chest during sleep, waking up multiple times in the evening. Morning after had heart palpitations and increased heart rate. Urgent Care visit with recommendation and subsequent visit to ER. ER visit ran routine labs and EKG, follow up with PCP recommended. After initial ER visit, two subsequent ER visits, two primary care visits, two urgent care visits. Symptoms include chest palpitations and pressure, constant increased heart rate, sweaty palms and feet, hollowness in stomach feeling, decreased appetite, frequent urination and bowel movement urges, general discomfort and body ache, lightheadedness, and occasional weakness and tingling in limbs. As a result of these symptoms there has been a significant increase in anxiety and increase in depression. Treatment includes: Propranolol10MG as needed, Metroprolol 25MG once daily, and ClonzaePAM .5MG as needed. Symptoms remain and not fully managed. Tests are ongoing.
17 yr old received for first dose vaccine.  Vaccine not approved for under 18yrs.
Rash on her chest; Rash on her chest & where she got the shot; Chills; Sweats; freezing and sweat it off; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), FEELING OF BODY TEMPERATURE CHANGE (freezing and sweat it off), RASH (Rash on her chest), VACCINATION SITE RASH (Rash on her chest & where she got the shot) and CHILLS (Chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A and 011F21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 19-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, the patient experienced HYPERHIDROSIS (Sweats), FEELING OF BODY TEMPERATURE CHANGE (freezing and sweat it off) and CHILLS (Chills). On 18-Nov-2021, the patient experienced RASH (Rash on her chest) and VACCINATION SITE RASH (Rash on her chest & where she got the shot). At the time of the report, HYPERHIDROSIS (Sweats), FEELING OF BODY TEMPERATURE CHANGE (freezing and sweat it off), RASH (Rash on her chest), VACCINATION SITE RASH (Rash on her chest & where she got the shot) and CHILLS (Chills) outcome was unknown.            No Concomitant product use was reported. No treatment information was provided.  The patient received their 2nd dose on 16-Nov-2021 and was fine that 1st day. On the next day, they had sweats and chills and would be freezing and sweat it off, freezing & sweat it off. On 18-Nov-2021, the patient noticed a rash on their chest & where they received the shot. The patient also had a history of Asthma.
Information has been received from a registered nurse concerning a female patient between the age of 19 and 39 years who between 23-OCT-2006 and 27-OCT-2006 was vaccinated subcutaneously with a dose of Pneumovax 23 (lot #654981/0674F).  Subsequently, in October 2006, the patient developed swelling and warmth in the vaccinated arm.  Unspecified medical attention was sought and the patient was treated with unspecified antibiotics.  At the time of report, the patient was recovering.  The nurse requested a lot lot check for lot number 0674F.  No product quality complaint was involved.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements of the agency and was released by the regulatory agency.  Additional information has been requested.
Pt vax with 1st dose 30Jul91. On 2Aug91 exp fatigue & weakness. On 7Aug91 exp pain on one side of face from jaw to sinus area, which lasted 2-3 days then resolved. 14Aug91 exp superficial chest pain in a band like distribution around chest.
About 9 days after receiving Moderna booster, I developed severe pain in my right knee.  Pain was so severe that I could barely walk and needed a cane for assistance.  On 12/26, I went to Orthopedics Urgent Care.  They x-rayed and it no skeletal issues were observed.  They provided a shot of Cortisone and advised to treat with rest and cold.   The Cortisone shot seemed to work for a period of 4-5 weeks and then a severe relapse occured.  I requested and was granted PT services.  The services did not resolve the issue.  I was seen again by doctor and another shot of cortisone was provided.  This dose didn't provide much relief.  I continued PT to limited effect.  As of today - May 4th 2022 the pain in my knee persists.  Note that there was NO physical trauma or injury to cause this injury.
I was feeling weak after I woke up. I took a shower, and then I nearly fainted. I dried off and then laid on the sofa. I felt sick and threw up blood so I went to the ER. When I was at the ER I had passed out. I was given IV fluids and they repaired 2 ulcers I had. I was hospitalized for 3 days. They did a blood transfusion and IV liquids. I was prescribed pantoprazole 40 mg 2 x day and sucralfate 1gm. When the doctor checked my hemoglobin it was fine now. I don't believe the vaccine had anything to do with what happened.
Injection site swelling; Pass some blood through his urine; Severe lower back pain; Having to urinate a lot; Loose bowels; Very tired; His injection site is red; His injection site hurts; Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels) and FATIGUE (Very tired) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels), FATIGUE (Very tired), VACCINATION SITE ERYTHEMA (His injection site is red), VACCINATION SITE PAIN (His injection site hurts) and VACCINATION SITE SWELLING (Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site). On 25-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling). The patient was treated with IBUPROFEN ongoing since an unknown date for Pain, at a dose of UNK dosage form. On 19-Mar-2021, VACCINATION SITE SWELLING (Swelling in his right arm that's about 1.5 inch x 1.5 inch at the injection site) had resolved. At the time of the report, BLOOD URINE PRESENT (Pass some blood through his urine), BACK PAIN (Severe lower back pain), POLLAKIURIA (Having to urinate a lot), DIARRHOEA (Loose bowels), FATIGUE (Very tired), VACCINATION SITE ERYTHEMA (His injection site is red) and VACCINATION SITE PAIN (His injection site hurts) outcome was unknown and VACCINATION SITE SWELLING (Injection site swelling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Reporter information updated, event added.